{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:39:33Z","timestamp":1774453173347,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GlaxoSmithKline foundation","doi-asserted-by":"publisher","award":["214165"],"award-info":[{"award-number":["214165"]}],"id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["190195702"],"award-info":[{"award-number":["190195702"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,3,2]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antimicrobial resistance genes (ARGs) in the respiratory microbiome are poorly characterised. We compared the presence of ARGs in healthy controls with patients with chronic lung disease in a cross-sectional study, adjusted for time since antibiotic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bronchoalveolar lavage was collected from 100 controls, and 93 patients with chronic obstructive pulmonary disease (COPD), 13 with asthma, 34 with sarcoidosis, 12 with idiopathic pulmonary fibrosis (IPF) and 11 patients with unclassifiable interstitial lung disease (uILD). Participants had not used antibiotics 14 days prior to sampling. Shotgun metagenomic sequencing was performed with Illumina NovaSeq. ARGs were identified using the National Database of Antibiotic-Resistant Organisms. Sample reads were normalised to counts per million.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 38% of controls had at least one ARG, compared with 51%, 39%, 65% and 83% of patients with COPD, asthma, sarcoidosis and IPF, respectively (p=0.01). ARGs against tetracycline (33%) were the most common ARG class, followed by beta-lactam and macrolide resistance (both 26%). In a logistic regression analysis adjusted for sex, age, body composition, smoking and antibiotic use, the OR (95%\u2009CI) for having ARGs in the lower airways was 1.30 (0.70 to 2.41) in COPD, 1.00 (0.29 to 3.52) in asthma, 3.52 (1.40 to 8.83) in sarcoidosis, 6.40 (1.25 to 32.73) in IPF and 3.27 (0.76 to 14.16) in uILD compared with controls. Overall mean (SD) ARG counts per million were 403.8 (537.7) in the 35 subjects who had used antibiotics \u22643 months before bronchoscopy, compared with 197.6 (355.9) in the 228 subjects without (p=0.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The presence of ARGs in the lower airways microbiome was significantly higher in patients with sarcoidosis and IPF than in controls. The counts per million for ARGs were significantly associated with recent antibiotic use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003864","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:40:18Z","timestamp":1774449618000},"page":"e003864","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance genes and antibiotic use in chronic lung disease: a bronchoscopy study of the lower airways microbiome"],"prefix":"10.1136","volume":"13","author":[{"given":"Guri D.","family":"Kringeland","sequence":"first","affiliation":[{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Vestland, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-5306","authenticated-orcid":false,"given":"Solveig","family":"Tangedal","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Vestland, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Julian","sequence":"additional","affiliation":[{"name":"Sequentia Biotech SL, Barcelona, Catalonia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreu","family":"Paytuv\u00ed-Gallart","sequence":"additional","affiliation":[{"name":"Sequentia Biotech SL, Barcelona, Catalonia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Sanseverino","sequence":"additional","affiliation":[{"name":"Sequentia Biotech SL, Barcelona, Catalonia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5319-525X","authenticated-orcid":false,"given":"Randi J.","family":"Bertelsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar R.","family":"Huseb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Vestland, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel S.","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Vestland, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sverre","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Vestland, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2799-0430","authenticated-orcid":false,"given":"Rune","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8725-9960","authenticated-orcid":false,"given":"Tomas M. L.","family":"Eagan","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2026032507400976000_13.1.e003864.1","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030492","article-title":"The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study","volume":"9","author":"Linnane","year":"2021","journal-title":"Microorganisms"},{"key":"2026032507400976000_13.1.e003864.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207235"},{"key":"2026032507400976000_13.1.e003864.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the Lung Microbiome in the \u201cHealthy\u201d Smoker and in COPD","volume":"6","author":"Erb-Downward","year":"2011","journal-title":"PLoS ONE"},{"key":"2026032507400976000_13.1.e003864.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS One"},{"key":"2026032507400976000_13.1.e003864.5","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00015-2018","article-title":"Microbial and host immune factors as drivers of COPD","volume":"4","author":"Mika","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026032507400976000_13.1.e003864.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047305","article-title":"The lung microbiome in moderate and severe chronic obstructive pulmonary disease","volume":"7","author":"Pragman","year":"2012","journal-title":"PLoS One"},{"key":"2026032507400976000_13.1.e003864.7","doi-asserted-by":"crossref","unstructured":"Tangedal S , Nielsen R , Aanerud M , et al . Lower airway microbiota in COPD and healthy controls. Thorax 2024. doi:10.1136\/thorax-2023-220455","DOI":"10.1136\/thorax-2023-220455"},{"key":"2026032507400976000_13.1.e003864.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262082","article-title":"The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease","volume":"17","author":"Knudsen","year":"2022","journal-title":"PLoS ONE"},{"key":"2026032507400976000_13.1.e003864.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0541OC"},{"key":"2026032507400976000_13.1.e003864.10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1164\/rccm.202002-0460OC","article-title":"The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis","volume":"203","author":"Invernizzi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032507400976000_13.1.e003864.11","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01362-4","article-title":"The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis","volume":"10","author":"Knudsen","year":"2022","journal-title":"Microbiome"},{"key":"2026032507400976000_13.1.e003864.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00473-0"},{"key":"2026032507400976000_13.1.e003864.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1\/ATTACHMENT\/4F9FA746-A486-4BC0-BF71-075D4D1D6D56\/MMC3.PDF"},{"key":"2026032507400976000_13.1.e003864.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201911-2202oc"},{"key":"2026032507400976000_13.1.e003864.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44353-1","article-title":"The antibiotic resistance reservoir of the lung microbiome expands with age in a population of critically ill patients","volume":"15","author":"Chu","year":"2024","journal-title":"Nat Commun"},{"key":"2026032507400976000_13.1.e003864.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01072-4","article-title":"Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections","volume":"14","author":"Serpa","year":"2022","journal-title":"Genome Med"},{"key":"2026032507400976000_13.1.e003864.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1059OC"},{"key":"2026032507400976000_13.1.e003864.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-02835-w","article-title":"Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"25","author":"Motta","year":"2024","journal-title":"Respir Res"},{"key":"2026032507400976000_13.1.e003864.19","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213485"},{"key":"2026032507400976000_13.1.e003864.20","doi-asserted-by":"crossref","first-page":"26196","DOI":"10.3402\/ecrj.v1.26196","article-title":"The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences","volume":"1","author":"Gr\u00f8nseth","year":"2014","journal-title":"Eur Clin Respir J"},{"key":"2026032507400976000_13.1.e003864.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2026032507400976000_13.1.e003864.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00194209"},{"key":"2026032507400976000_13.1.e003864.23","doi-asserted-by":"crossref","unstructured":"Hoang T , Wiker H , Mikal L Eagan T , et al . 16S amplicon pcr for the v3-v4 region for the microcopd samples v1. Published protocol [Preprint] 2019. doi:10.17504\/protocols.io.2sygefw","DOI":"10.17504\/protocols.io.2sygefw"},{"key":"2026032507400976000_13.1.e003864.24","unstructured":"Bushnell B . BBMap: a fast, accurate, splice-aware aligner. Conference: 9th Annual Genomics of Energy & Environment Meeting; 2014:17\u201320."},{"key":"2026032507400976000_13.1.e003864.25","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923"},{"key":"2026032507400976000_13.1.e003864.26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu739"},{"key":"2026032507400976000_13.1.e003864.27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/antibiotics11030339","article-title":"Review and Comparison of Antimicrobial Resistance Gene Databases","volume":"11","author":"Papp","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026032507400976000_13.1.e003864.28","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3176"},{"key":"2026032507400976000_13.1.e003864.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-020-03802-0","article-title":"In silico benchmarking of metagenomic tools for coding sequence detection reveals the limits of sensitivity and precision","volume":"21","author":"Golob","year":"2020","journal-title":"BMC Bioinformatics"},{"key":"2026032507400976000_13.1.e003864.30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00212","article-title":"Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life","volume":"10","author":"Allemann","year":"2019","journal-title":"Front Microbiol"},{"key":"2026032507400976000_13.1.e003864.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix881"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:40:25Z","timestamp":1774449625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjresp-2025-003864"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003864","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}